Review Product Marketing Authorisation For Human Use «Agemo».

Original Language Title: Modifica dell'autorizzazione all'immissione in commercio delmedicinale per uso umano «Agemo».

Read the untranslated law here:

Retrieved February 23, 2015 V&A # 343/2015 of Procedure determines EU # UK/H/5252/001/II/001 type II variation: B.I. to z) are authorized the following variation: ASMF update for the active ingredient supplied by the manufacturer "BASF Pharma (Callanish) Ltd" in relation to medicine AGEMO and authorised pack sizes the placing in Italy following the mutual recognition procedure.
MAh: Teva Italy S.r.l.
Inventory disposal lots already products can be kept on the market until the expiration date printed on the label of the medicinal product in accordance with art. 1 subparagraph 5 of determines AIFA n. 371 of 14/04/2014 published in the Official Journal No. 101 of 3/05/2014.
Date of application of the determination on the day following that of its publication, to decompress, in Gazzetta Ufficiale della Repubblica italiana.